Cronos Group stock stands 39.57 percent above the USD 2.30 target

Published on 10/17/2026 at 22:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue rose 58.00 percent to USD 53.00 million. Cronos Group stock costs EUR 2.87 on October 16, 2026, up 0.31 percent on Nasdaq.

Target and operating figures

MarketBeat cited a USD 2.30 average target from five brokerages on October 7, 2026.
Cronos reported USD 53.00 million in second-quarter revenue, up 58.00 percent year over year.
Cronos Group stock costs EUR 2.87 at Lang & Schwarz on October 16, 2026 at 11:00 p.m. CEST, plus 0.31 percent on Nasdaq.
Cronos trades at a P/E ratio of 17.19 and a USD 1.2 billion market capitalization.

CRON, CA22717L1013, Illustration mit AI erstellt.

MarketBeat cited a USD 2.30 average 12-month target from five brokerages for Cronos Group on October 7, 2026. With the Nasdaq price at USD 3.21 on October 16, 2026, the stock stood 39.57 percent above that target. The last quote at Lang & Schwarz was EUR 2.87 on October 16, 2026 at 11:00 p.m. CEST; the Nasdaq daily change was plus 0.31 percent versus its prior close.

Revenue growth sets the operating tone

Cronos reported USD 53.00 million in second-quarter 2026 revenue, a 58.00 percent increase from the same quarter a year earlier, according to Benzinga. Gross profit reached USD 28.50 million, up 96.00 percent year over year. The company said higher sales volumes, average selling prices and international demand supported the result.

The same earnings call showed adjusted EBITDA of USD 13.10 million in the second quarter, compared with an improvement of USD 11.40 million from the prior-year quarter. Cronos also reported USD 827.00 million in cash, cash equivalents, short-term investments and non-current interest-bearing deposits at the end of the quarter.

Price position and trading frame

The Nasdaq price of USD 3.21 sits 11.08 percent below the 52-week high of USD 3.61 and 40.79 percent above the 52-week low of USD 2.28. Trading volume was 863,317 shares on October 16, 2026, against an average volume of 1,140,434 shares.

Valuation and November date

Cronos had a market capitalization of USD 1.2 billion and a P/E ratio of 17.19 on October 16, 2026. The five-brokerage consensus target cited by MarketBeat was USD 2.30, while the company identifies November 5, 2026 as the date for its third-quarter earnings call on its Cronos Group investor-relations page.

Comparison with peers

CRON (Nasdaq, USD): plus 0.31 percent, P/E 17.19, market capitalization USD 1.2 billion.

Canopy Growth (Nasdaq, USD): minus 3.06 percent, P/E minus 1.50, market capitalization USD 301.6 million.

Tilray Brands (Nasdaq, USD): minus 5.30 percent, P/E minus 2.17, market capitalization USD 340.0 million.

Three figures frame the stock

Cronos describes its business as a global cannabis company built around branded products including Spinach, PEACE NATURALS, LIT and Lord Jones. The operating figures point to strong quarterly growth, while the analyst average remains below the latest Nasdaq price.

On Nasdaq, the company is listed under CRON and trades in USD, as identified in the company announcement carried by Nasdaq. The next scheduled earnings call is November 5, 2026 at 8:30 a.m. ET.

The stock was last at EUR 2.87 at Lang & Schwarz on October 16, 2026 at 11:00 p.m. CEST; the Nasdaq daily change was plus 0.31 percent versus its prior close. The further course of trading is shown by the continuously updated real-time quote of Cronos Group stock.